Barely Significant
← all excerpts

Randomized Adjuvant Chemotherapy of EGFR-Mutated Non-Small Cell Lung Cancer Patients with or without Icotinib Consolidation Therapy.

PLoS One · 2015 · PMC4608803 · PMID 26474174

Europe PMCDOI
1
hedged sentence
0.0660
closest p · 1.3× alpha
0.0660
boldest claim

The sentences

did not reach statistical significancep = 0. 066so close (0.05 < p ≤ 0.1)
Our results suggested that combined chemotherapy and icotinib treatment tended to elicit a longer duration of DFS when compared with chemotherapy treatment alone in NSCLC patients with EGFR sensitive mutations, although the difference in DFS between the two treatment groups did not reach statistical significance (p = 0. 066 at the best) in the log-rank test.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.